Amniotics AB Statements
AM
Data from Amniotics AB`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency :
SEK - Swedish krone
Last reporting period :
31 Mar, 2023
New report :
—
Reporting period :
Quarterly
Earnings release date:
—
Expected release date:
—
Amniotics AB Income Statement
B
M
SEK (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
—
0
6.655
0
10.979
-30.4 %
0
-10.979
30.4 %
0
-0.612
0
0.001
0
-11.59
29.4 %
0
—
0
-11.59
29.4 %
0
-0.016
710.14
—
—
100
—
0
—
—
0
—
0
4.802
0
15.778
48.8 %
0
-15.778
-48.8 %
0
-0.637
0
—
0
-16.415
-53.7 %
0
—
0
-16.415
-53.7 %
0
-0.1
164.84
—
—
100
—
0
—
—
0
—
0
3.696
0
10.605
-3.7 %
0
-10.605
3.7 %
0
-0.077
0
—
0
-10.682
3 %
0
—
0
-10.682
3 %
0
-0.065
164.84
—
—
100
—
0
—
—
0
—
0
4.709
0
11.011
-16.8 %
0
-11.011
16.8 %
0
—
0
—
0
-11.011
16.8 %
0
—
0
-11.011
16.8 %
0
-0.228
48.397
—
—
100
—
0
—
—
0
—
0
4.403
0
13.239
29.7 %
0
-13.239
-29.7 %
0
—
0
—
0
-13.239
-29.7 %
0
—
0
-13.239
-29.7 %
0
-0.824
16.066
—
—
100
—
0
—
—
0
—
0
3.565
0
10.211
-42.2 %
0
-10.211
42.2 %
0
—
0
—
0
-10.211
42.2 %
0
—
0
-10.211
42.2 %
0
-0.636
16.066
—
—
100
—
0
—
—
0
—
0
4.261
0
17.666
—
0
-17.666
—
0
-0.004
0
—
0
-17.67
—
0
—
0
-17.67
—
0
-1.114
15.862